Generative AI can be used to combat misinformation. However, it can also exacerbate the problem by producing convincing ...
Explore the parallels and differences between AI architectures and the human brain's design and functionality in processing ...
New presentations for tildrakizumab-asmn explore real-world use in U.S. patients using Medicare New data specific to patients ...
Q4 2025 Earnings Call February 26, 2026 4:30 PM ESTCompany ParticipantsMike Brophy - Chief Financial OfficerSteve Chapman - CEO ...
Enterprise AI adoption looks strong, but real ROI lags. Why coordination theater, shadow IT and stalled redesign are distorting compounding value.
Opinion
The 'New World Order' and the media: Between power balances and the construction of perception
The debate surrounding the so-called “new international order” has persisted not because the concept lacks relevance, but because it resists simple definition.
Actigraphy data show irregular sleep-wake rhythms nearly double the risk for relapse in individuals with remitted major depressive disorder.
The World Economic Forum's Global Risks Report 2025 identified 7 of the top 10 long-term business risks as ESG-related.
Q2 2026 Earnings Call February 26, 2026 5:00 PM ESTCompany ParticipantsPaul Hughes - Joint Company SecretarySilviu Itescu ...
Machine learning enhances proteomics by optimizing peptide identification, structure prediction, and biomarker discovery.
The recent Public Services Association (PSA) wage settlement could have far-reaching implications for Trinidad and Tobago’s ...
Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its fourth quarter and full year 2025 financial results and provided a corporate update.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results